Zusammenfassung
Der zeitliche Verlauf pathologischer Ereignisse bei Sauerstoffmangel im Hirngewebe konnte in den letzten Jahren genauer beschrieben werden. Dies wurde dadurch möglich, daß parallel zur Messung des Intermediärstoffwechsels die interstitielle Konzentration verschiedener Ionen mittels ionenselektiver Elektroden gemessen werden kann. Eine solche Messung ist in Abb. 1 dargestellt. Bei Ratten wurde eine Anoxie durch Stickstoffbeatmung induziert. Ionenselektive Elektroden, die 1000 µm unterhalb des Kortex positioniert wurden, registrierten die H+-, K+- und Ca++-Aktivitäten kontinuierlich. Darüber hinaus wurde das DC-Potential, Ausdruck des neuronalen Membranpotentials, gemessen.
Preview
Unable to display preview. Download preview PDF.
Literatur
Akermann KEO, Heinonen E (1983) Qualitative measurements of cytosolic calcium ion concentration within islated guinea-pig nerve endings using entrapped arsenazo III. Biochim biophys Acta 732: 117–121
Borgers M, Van Reempts J (1984) The distribution of calcium in normal and ischemic brain tissue. Clin Res Rev, Vol 4: 70–71
Campbell AK (1985) Intracellular calcium, its universal role as regulator ( Wiley & Sons, Chichester )
Demeyere R, Flameng W (1986) Hemodynamic effects of intravenous flunarizine in patients with coronary artery disease. V II European Congress of Anaesthesiology, Vienna
Deshpande JK, Wieloch T (1985) Amelioration of ischemic brain damage by postischaemic treatment with flunarizine. Neurological Research 7: 27–29
Edmonds Jr HL, Wauquier A, Melis W, Van den Broeck WAE, Van Loon J, Janssen PAJ (1985) Improved short-term neurological recovery with flunarizine in a canine model of cardiac arrest. Am J Emerg Med 3: 150–155
Heinonen E, Akerman KE, Kaila K, Scott IG (1985) Dependence of cytoplasmic calcium transients on the membrane potential in isolated nerve endings of the guinea pig. Biochim Biophys Acta 815 (2) 203–208
Höller M, Dierking H, Dengler K, Tegtmeier F, Peters T (1986) In: Acute brain ischemia medical and surgical therapy, Eds. Noé Battistine et al., 1986, 229–236, Raven Press, New York
Holmes B, Brogden RN, Heel RC, Speight TM, Avery GS (1984) Flunarizine — A Review of its pharmacodynamic and pharmacokinetic properties and therapeutic use. Drugs 27: 6–44
Jones AW (1981) Vascular smooth muscle and alterations during hypertension; in Bülbring, Brading, Jones, Tornita, Smooth muscle, pp 397–430 ( Arnold, London )
Latorre R (1984) Coronado R, Vergara C (1984) K’ channels gated by voltage and ions. A Rev Physiol 46, 485–495
Ullmann H, Peters Th (1976) On the sarcolemmal site of action of cardiac glycosides; in Roy, Dhalla, Recent advances in studies on cardiac structure and metabolism, vol. 9, The sarcolemma, pp 311–328 ( University Park Press, Baltimore )
Lux HD, Hofmeier G (1982) Properties of calcium-and voltage-activated potassium current in helix pomatia neurons. Pflügers Arch 394, 61–69
McDonald TF, Nawrath H, Trautwein W (1975) Membrane currents and tension in cat ventricular muscle treated with cardiac glycosides. Circ Res, 37: 674–682
Scheufler E, Wilhelm DI, Peters Th (1986) Effects of calcium modulating compounds on ionic contents in ouabain toxicity. Arch Pharmacol 334 suppl, R 31
Silverstein FS, Buchanan K, Hudson Ch, Johnston M (1986) Flunarizine limits hypoxia-ischemia induced morphologic injury in immature rat brain. Stroke 17, 477–482
Tegtmeier F, Dengler K, Zacharias E, Eichhorn R, Höller M (1987) Brain concentrations and effect of cerebroprotective drugs — investigations with flunarizine and R 56865, Precl Res Report, Janssen Research Foundation
Vendesteene A, Trempont V, Verborgh C, de Rood M, Focroul M, Walrant P, Schoutens A, D’haens, J (1985) Effects of flunarizine on cerebral blood flow and metabolism in man. Research report on file, Janssen
Van Nueten JM, Vanhoutte PM (1980) Calcium entry blockers and vaso-spasm. Proceedings of “Mechanisms of vasodilatation”, Wilrijk, satellite symposium of the XXXVIII Int. Congress of Physiological Science
Van Reempts J, Borgers M, Van Deal L, Van Eyndhoven, Van De Ven M (1983) Protection with flunarizine against hypoxic-ischaemic damage of the cerebral cortex. A quantitative morphologic assessment. Arch int. Pharmacodyn 262, 76–88
Wauquier A, Clincke G, Van Den Broeck WAE, Hermans C, Melis W, Van Loon J (1984) In: Brain Ischemia: Quantitative EEG and Imaging Techniques, Progress in Brain Research, Vol 62, Eds G Pfurtscheller, EJ Jonkman and FH Lopes da Silva, 217–233
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Peters, T. (1988). Pharmakologische Begründung für die therapeutische Anwendung von Flunarizin bei zerebraler Hypoxie, Anoxie und Ischämie. In: Hofferberth, B., Brune, G.G. (eds) Calcium-Antagonisten in der Neurologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73300-0_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-73300-0_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-18723-3
Online ISBN: 978-3-642-73300-0
eBook Packages: Springer Book Archive